2025年4月23日

Ready to start using GenAI in your medical and regulatory writing? Watch this webinar for everything you need to know.

Data Science and AI Client Solutions Architect
Ian Kerman is a Data Science and AI Client Solutions Architect at Certara, where he leads initiatives at the intersection of artificial intelligence, data science, and life sciences. With over 15 years of industry experience, Ian brings deep expertise in machine learning, MLOps, and scientific informatics, helping life sciences organizations translate complex data into actionable insights. At Certara, he spearheads advanced R&D efforts in large language models, user experience design, and integrated biological and chemical data knowledge systems.
Before joining Certara, Ian held leadership roles at LabVoice and BIOVIA (Dassault Systèmes), where he led cross-functional teams to deliver AI-powered solutions, voice-enabled lab assistants, and custom data platforms for pharma and biotech customers. His work has contributed to innovations in computational drug discovery, antibody developability prediction, and laboratory automation.
Ian is also an experienced educator and advocate for scientific collaboration. He has developed and delivered technical training programs, mentored students on AI-focused research projects, and co-founded the Data Science and AI Topical Interest Group with the Society for Laboratory Automation and Screening (SLAS). A frequent speaker at industry conferences, Ian combines technical depth with a passion for advancing AI in the life sciences.
Ian earned an M.S. in Computer Science, focusing on Machine Learning, from the Georgia Institute of Technology and an M.S. in Biology, alongside undergraduate degrees in Bioinformatics and Molecular Biology from the University of California, San Diego.
1 https://openai.com/index/chatgpt/
2 https://www2.deloitte.com/us/en/pages/life-sciences-and-health-care/articles/value-of-genai-in-pharma.html
3 https://www.bcg.com/press/24october2024-ai-adoption-in-2024-74-of-companies-struggle-to-achieve-and-scale-value
CoAuthorによる規制文書作成の未来を体験しましょう
CoAuthorが規制文書作成プロセスをどのように革新できるか、無料のデモでぜひご体験ください。